Serum Soluble ST2 and Plaque Vulnerability in Patients With Acute Coronary Syndrome

NCT04797819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-03-24

No results posted yet for this study

Summary

This study aimed to assess the association between serum sST2 level and plaque vulnerability in ACS patients. It is hypothesized that serum sST2 level may be related to plaque components and closely associated with plaque vulnerability.

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Coronary plaque components

Coronary plaque components were detected by CCTA method

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Song Ding · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797819 on ClinicalTrials.gov